45 results on '"Waters, Justin"'
Search Results
2. Stenting the Upper/Cervical Oesophagus with a Proximal Deployment Cervical Oesophageal Stent: Technique and Outcomes
3. Gastrointestinal cancer
4. Investigation of BCL-2 antisense oligonucleotide G3139 in the treatment of patients with non-Hodgkin's lymphoma
5. Fluoroscopic Guided Transluminal Biopsy of the Oesophagus and Ureter with a Biliary Biopsy Forceps Kit
6. Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
7. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
8. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
9. Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial
10. Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
11. Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
12. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply
13. Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
14. FOLFOX as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
15. Optimising Chemotherapy for Frail and Older Patients With Advanced Gastroesophageal Cancer: The GO2 Phase III Trial
16. Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
17. Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
18. Management of Anemia in Patients Receiving Chemotherapy
19. Adjuvant chemotherapy
20. Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma
21. Colorectal cancer
22. Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
23. Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.
24. SUN-LB057 An Interesting Case of Multiple Pancreatic Neuroendocrine Tumour: Normoglycaemic Glucagonoma and Concurrent Gastrinoma
25. Three differently timed presentations of dermatomyositis associated with advanced ovarian cancer
26. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
27. NiCCC (ENGOT-GYN1): A randomized phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear-cell carcinoma of the ovary or endometrium.
28. Novel machine learning algorithm to predict response to immunotherapy in patients with small cell and non-small cell lung cancer.
29. Changes in plasma biomarkers over time in patients (pts) with advanced biliary tract cancer (ABC) treated in the UK ABC-03 randomized phase II trial.
30. ABC-03: A randomized phase II trial of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine (CisGem) chemotherapy for patients (pts) with advanced biliary tract cancer (ABC).
31. Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.
32. Prognostication in esophagogastric adenocarcinoma (OGA): Factors influencing overall survival (OS) in REAL3.
33. A restrospective analysis of toxicities encountered with palliative epirubicin, oxaliplatin, and capecitabine (EOX) chemotherapy for advanced esophagogastric cancer.
34. Outcome of second-line chemotherapy for biliary tract cancer
35. A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3).
36. Palliative treatments for patients with inoperable gastroesophageal cancers
37. O-251 Weight loss and anaemia are poor prognostic factors for patients with lung cancer receiving chemotherapy — will modification of these prognostic factors become a new standard of care?
38. Human Bcl-2 antisense therapy for lymphomas
39. New Approaches to the Treatment of Gastro-lntestinal Cancer
40. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
41. Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
42. Classification versus search-which is more important?
43. As usual there is no simple answer. But here are the answers to some common questions that will help you to decide.
44. Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
45. Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.